• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现实临床环境中的血压变异性与心血管事件及死亡风险

Blood Pressure Variability and Risk of Cardiovascular Events and Mortality in Real-World Clinical Settings.

作者信息

Li Hsin-Lun, Lin Hung-Ju, Muo Chih-Hsin, Lu Chung-Yen, Kuo Chin-Chi, Chen Pei-Chun

机构信息

Department of Applied Mathematics National Sun Yet-sen University Kaohsiung Taiwan.

Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.

出版信息

J Am Heart Assoc. 2025 Jun 3;14(11):e037658. doi: 10.1161/JAHA.124.037658. Epub 2025 May 26.

DOI:10.1161/JAHA.124.037658
PMID:40417802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12229178/
Abstract

BACKGROUND

The real-world applicability of long-term blood pressure (BP) variability measurements remains underexplored. We evaluated the association between visit-to-visit BP variability and the risk of cardiovascular events and all-cause mortality using electronic health records.

METHODS

In this retrospective cohort study at a large academic medical center in Taiwan, we calculated the variability independent of the mean (VIM) and average real variability of BP using electronic health records of 16 945 adults with at least one outpatient BP measurement in any 3 consecutive years from 2012 to 2017. We used Cox proportional hazards models to assess associations between BP variability and cardiovascular events, including cardiovascular deaths, and all-cause mortality through 2020.

RESULTS

Over a median follow-up of 4 years, 317 patients experienced cardiovascular events, and 582 died. Adjusted hazard ratios (HRs) for cardiovascular events increased gradually across both VIM and average real variability quartiles of BP. The adjusted HRs (95% CIs) per interquartile range increase in systolic BP variability was 1.24 (1.09-1.41) for VIM and 1.11 (1.01-1.23) for average real variability. For diastolic BP, the HRs (95% CIs) were 1.22 (1.09-1.36) and 1.13 (1.02-1.24), respectively. Similar results were observed for all-cause mortality except a weaker association with average real variability of diastolic BP (HR, 1.08 [95% CI, 0.99-1.17]). The association between VIM of BP and risk of cardiovascular events was consistent across patient subgroups.

CONCLUSIONS

In the electronic health records analysis, visit-to-visit BP variability was independently associated with the risk of cardiovascular events and all-cause mortality. Our findings indicate the applicability of BP variability indices in real-world health care settings.

摘要

背景

长期血压(BP)变异性测量在现实世界中的适用性仍未得到充分探索。我们使用电子健康记录评估了就诊间血压变异性与心血管事件风险及全因死亡率之间的关联。

方法

在台湾一家大型学术医疗中心进行的这项回顾性队列研究中,我们利用2012年至2017年连续3年中至少有一次门诊血压测量记录的16945名成年人的电子健康记录,计算了独立于均值的变异性(VIM)和血压的平均实际变异性。我们使用Cox比例风险模型评估血压变异性与心血管事件(包括心血管死亡)以及截至2020年的全因死亡率之间的关联。

结果

在中位随访4年期间,317名患者发生了心血管事件,582人死亡。在血压的VIM和平均实际变异性四分位数中,心血管事件的调整后风险比(HR)均逐渐增加。收缩压变异性每增加一个四分位数间距,VIM的调整后HR(95%CI)为1.24(1.09 - 1.41),平均实际变异性为1.11(1.01 - 1.23)。对于舒张压,HR(95%CI)分别为1.22(1.09 - 1.36)和1.13(1.02 - 1.24)。除了与舒张压平均实际变异性的关联较弱(HR,1.08 [95%CI,0.99 - 1.17])外,全因死亡率也观察到类似结果。血压VIM与心血管事件风险之间的关联在各患者亚组中是一致的。

结论

在电子健康记录分析中,就诊间血压变异性与心血管事件风险及全因死亡率独立相关。我们的研究结果表明血压变异性指数在现实世界的医疗环境中具有适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff4/12229178/09874bc3b597/JAH3-14-e037658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff4/12229178/09874bc3b597/JAH3-14-e037658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff4/12229178/09874bc3b597/JAH3-14-e037658-g001.jpg

相似文献

1
Blood Pressure Variability and Risk of Cardiovascular Events and Mortality in Real-World Clinical Settings.现实临床环境中的血压变异性与心血管事件及死亡风险
J Am Heart Assoc. 2025 Jun 3;14(11):e037658. doi: 10.1161/JAHA.124.037658. Epub 2025 May 26.
2
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
3
Blood pressure targets for hypertension in older adults.老年人高血压的血压目标
Cochrane Database Syst Rev. 2017 Aug 8;8(8):CD011575. doi: 10.1002/14651858.CD011575.pub2.
4
Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study.心血管-肾脏-代谢综合征与全因死亡率和心血管死亡率:一项回顾性队列研究。
PLoS Med. 2025 Jun 26;22(6):e1004629. doi: 10.1371/journal.pmed.1004629. eCollection 2025 Jun.
5
Blood pressure targets for hypertension in people with chronic renal disease.高血压合并慢性肾脏病患者的血压目标。
Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.
6
Visit-to-Visit Blood Pressure Variability as a Risk Factor for All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events Among American Indians: the Strong Heart Study.就诊间血压变异性作为美国印第安人全因死亡率、心血管死亡率和主要不良心血管事件的危险因素:强心研究
Prev Chronic Dis. 2025 Jun 26;22:E30. doi: 10.5888/pcd22.240512.
7
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
8
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
9
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.高血压和心血管疾病患者治疗的血压目标
Cochrane Database Syst Rev. 2017 Oct 11;10(10):CD010315. doi: 10.1002/14651858.CD010315.pub2.
10
Antihypertensive withdrawal for the prevention of cognitive decline.停用抗高血压药物以预防认知功能减退。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD011971. doi: 10.1002/14651858.CD011971.pub2.

本文引用的文献

1
Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.血压治疗对心血管事件的遗留益处主要通过改善血压变异性来介导:ASCOT 试验。
Eur Heart J. 2024 Apr 1;45(13):1159-1169. doi: 10.1093/eurheartj/ehad814.
2
Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial.随访间血压变异性与强化降压与标准降压治疗患者心血管结局的关系:来自 STEP 试验的见解。
Hypertension. 2023 Jul;80(7):1507-1516. doi: 10.1161/HYPERTENSIONAHA.122.20376. Epub 2023 May 12.
3
How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022.
2020-2022 年台湾地区应对 COVID-19 疫情的措施和 COVID-19 疫情对台湾地区的影响。
J Microbiol Immunol Infect. 2023 Jun;56(3):433-441. doi: 10.1016/j.jmii.2023.04.001. Epub 2023 Apr 6.
4
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review.台湾地区医疗数据库中诊断编码的验证:文献回顾。
Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):795-811. doi: 10.1002/pds.5608. Epub 2023 Mar 27.
5
Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗.血压变异性:方法学方面、临床相关性和管理的实用指标——欧洲高血压学会立场文件∗。
J Hypertens. 2023 Apr 1;41(4):527-544. doi: 10.1097/HJH.0000000000003363. Epub 2023 Feb 15.
6
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management.COVID-19 大流行对心血管疾病预防和管理的影响。
Nat Med. 2023 Jan;29(1):219-225. doi: 10.1038/s41591-022-02158-7. Epub 2023 Jan 19.
7
Variability independent of mean blood pressure as a real-world measure of cardiovascular risk.独立于平均血压的变异性作为心血管风险的一种现实世界衡量指标。
EClinicalMedicine. 2022 May 13;48:101442. doi: 10.1016/j.eclinm.2022.101442. eCollection 2022 Jun.
8
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.台湾心脏病学会与台湾高血压学会2022年高血压管理指南
Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.
9
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.估算2019冠状病毒病大流行造成的超额死亡率:2020 - 2021年与2019冠状病毒病相关死亡率的系统分析
Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10.
10
Visit-to-visit office blood pressure variability combined with Framingham risk score to predict all-cause mortality: A post hoc analysis of the systolic blood pressure intervention trial.门诊血压变异性联合弗雷明汉风险评分预测全因死亡率:一项收缩压干预试验的事后分析。
J Clin Hypertens (Greenwich). 2021 Aug;23(8):1516-1525. doi: 10.1111/jch.14314. Epub 2021 Jul 3.